SABS SCHEDULE 13G/A: SEC filing

Woodline Partners LP

Filed with the SEC on · accession 0000919574-26-008061

SABS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Woodline Partners LP filed an amended Schedule 13G reporting beneficial ownership of 5,454,694 shares (5.7%) of SAB Biotherapeutics common stock, including shares underlying Series B preferred stock and warrants.

Summary of the filing

Woodline Partners LP filed an amended Schedule 13G reporting beneficial ownership of 5,454,694 shares (5.7%) of SAB Biotherapeutics common stock, including shares underlying Series B preferred stock and warrants. The filing is a passive investment disclosure with no stated intent to influence control.

Key details

Shares of Common Stock beneficially owned$5.5M
Shares of Common Stock directly held$1.2M
Shares issuable upon conversion of Series B preferred stock underlying Enrollment Warrants$2.9M
Shares issuable upon conversion of Series B preferred stock underlying Data Release Warrants$1.4M
Reporting person / beneficial ownerWoodline Partners LP
IssuerSAB Biotherapeutics, Inc.
Direct holder of the securitiesWoodline Master Fund LP
General counsel & chief compliance officer, woodline partners lpErin Mullen

✦ Ask GOAX AI about this filing — what it means for SABS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SABS?

Click here

Frequently asked questions

What did SABS file with the SEC on Nov 16, 2026?

SABS filed a SCHEDULE 13G/A (SEC filing). Woodline Partners LP filed an amended Schedule 13G reporting beneficial ownership of 5,454,694 shares (5.7%) of SAB Biotherapeutics common stock, including shares underlying Series B preferred stock and warrants. The filing is a passive investment disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other SABS SEC filings

Get alerts when SABS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days